Posts

Genentech lays off 103 as part of gRED rethink, advances with $490M breast cancer collaboration

on

ADC Therapeutics cuts 17% of staff after 27 patient deaths in Zynlonta trial

on

Genentech executes another round of layoffs, with 3 VPs axed

on

Valneva to cut up to 15% of jobs as reduced travel hits vaccine demand

on

Takeda Restructuring: Over 600 US Layoffs Amid $1.3B Transformation Plan

on

Gilead Cuts Over 300 Jobs at Arcellx Post-$7.8B Acquisition as BioNTech Plans 1,860 Layoffs

on

Replimune Lays Off 60% of Workforce After Second FDA Rejection of RP1 Melanoma Drug

on

Astellas Pharma to Close Seattle Universal Cells Office with 50 Employee Layoffs

on

Click Therapeutics Lays Off 25 Employees After $50M Raise and CT-155 Commercial Restructuring

on

Novo Nordisk to Cut 400 Jobs at Bloomington, Indiana Facility Amid Prior Ownership Layoffs

on

IO Biotech Files for Chapter 7 Bankruptcy After FDA Refusal on Cancer Vaccine

on

Bicycle Therapeutics Downsizes by 30% After Deprioritizing Lead Cancer Drug Program

on

Inovio Trims Team as Trouble Brews at FDA for Rare Disease Candidate

on

Evotec Announces Up to 800 Job Cuts and Four Site Closures in Horizon Reorganization Phase

on

Ultragenyx Announces Layoff of 130 Employees Amid FDA Delays on UX111 Resubmission

on

2025 FDA staff cuts and their impact on new drug review timelines

on

Exclusive: Compounding giant Empower Pharmacy cuts hundreds of staff, stops New Jersey operations

on

Novartis Announces Plans to Lay Off 550 Workers at Swiss Factory

on

Merck Continues Cuts: 204 Employees Laid Off in New Jersey

on

Korro Bio Abandons Lead Genetic Disease Drug Candidate KRRO-110 After Disappointing Trial Data

on